Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
US9173858B2 · kind B2 · utility
0Cited by
12References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 16, 2012 |
| Grant date | Nov 3, 2015 |
| Priority date | — |
| Expiry date | Jun 17, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present technology relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present technology provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.